Senior male researcher carrying out scientific research in a lab (shallow DOF; color toned image)

Clinical Research Programs

NJU physicians are engaged in a variety of clinical research programs to evaluate new drugs, therapies, and treatments with the potential to find new cures for urologic disorders and diseases. We are proud of the leadership role our doctors take in helping to prove the safety and efficacy of new treatments, and the opportunity it gives us to make those options available to our patients. Those potential advantages, however, are always considered in the context of the overall health and well-being of our patients.

Our clinical research department has a dedicated research staff who will assist you through your entire journey. Our state-of-the-art facilities offer a locked storage area for all trial-specific documentation and Investigational Product (IP), -70°F freezers to store specimens and IP, electrocardiogram (ECG) machines, refrigerated centrifuges for precise temperature management and sample protection, and pharmacokinetics (PK) capabilities.

If you think you may be eligible for and interested in participating in a clinical research program, your NJU urologist will discuss the potential benefits and risks with you so that you and your family can make an informed decision.

EXPERIENCE

New Jersey Urology has extensive experience in conducting Phase 1b – IV trials in the following urological therapeutic areas:

  • Bladder cancer
  • BPH (Benign Prostatic Hyperplasia)
  • Erectile dysfunction/impotence
  • High Grade PIN
  • Hypogonadism
  • Neurogenic bladder
  • Overactive bladder
  • Premature ejaculation
  • Prostate cancer
  • Prostate cancer prevention
  • Prostatitis
  • Urinary incontinence
  • Urinary tract infection treatment

OUR SPONSORS

Our Clinical Research Department works with a variety of sponsor companies and contract research organizations, including:

  • Abbott
  • Advanced Biologics
  • Allergan
  • Amgen
  • Astra-Zeneca
  • Barr-Laboratories, Inc.
  • Bayer
  • Bionche
  • Boehringer Ingelheim Pharmaceuticals
  • Glaxo Smith Kline
  • GTx Inc.
  • Kendle International, Inc.
  • MDS Pharma Services
  • Merck
  • Novartis
  • Oakwood
  • Ortho-McNeil
  • Pallisades Pharmaceuticals
  • PCRS
  • Pfizer
  • Pharmacia
  • PPD
  • Quintiles
  • Schering-Phough
  • Spectrum
  • TAP Pharmaceutical Products, Inc.
  • Upjohn Company
  • Zentaris

CLINICAL TRIALS

If you’ve been diagnosed with enlarged prostate, or Benign Prostatic Hyperplasia (BPH), you may be eligible to participate in a clinical trial. For more information, please contact our research department at (856) 840-4563 or (856) 673-1613.

If you’ve been diagnosed with urologic cancer, such as bladder, kidney or prostate cancer, you may be eligible to participate in a clinical trial. For more information, please contact our research department at (856) 840-4563 or (856) 673-1613.

If you’ve been diagnosed with urinary incontinence, or Overactive Bladder (OAB), you may be eligible to participate in a clinical trial. For more information, please contact our research department at (856) 840-4563 or (856) 673-1613.

LOCATIONS

To make an appointment with an NJU physician with expertise in Clinical Research, please call one of the phone numbers listed below.

Mount Laurel

15000 Midlantic Drive, Suite 100
Mount Laurel, NJ 08054
Phone: (856) 840-4563

Voorhees

2401 Evesham Road, Suite F
Voorhees, NJ 08043
Phone: (856) 673-1613

Why Choose NJU?

At New Jersey Urology (NJU), our team of experienced urologists and clinical support professionals are dedicated to improving the health of our patients. As one of the country’s most prominent urology groups, we specialize in all areas of urological health and offer comprehensive treatment options, in-house laboratory testing and six state-of-the-art cancer treatment centers.

Discover the NJU difference today. Contact us and our administrative team will respond back to you as soon as possible.